Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.
about
Fluid Biomarkers of Traumatic Brain Injury and Intended Context of UseWhat's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentAntioxidant therapies in traumatic brain and spinal cord injuryAxonal pathology in traumatic brain injury.Location and level of Etk expression in neurons are associated with varied severity of traumatic brain injuryNrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice.Lipid peroxidation in brain or spinal cord mitochondria after injuryPhenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal.Therapy development for diffuse axonal injury.Propofol ameliorates calpain-induced collapsin response mediator protein-2 proteolysis in traumatic brain injury in ratsPomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review.Diffuse traumatic brain injury and the sensory brain.The role of calpains in traumatic brain injury.Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.Effect of Second-Hand Tobacco Smoke on the Nitration of Brain Proteins: A Systems Biology and Bioinformatics Approach.Lipid peroxidation and tyrosine nitration in traumatic brain injury: Insights into secondary injury from redox proteomics.The use of antioxidants in the treatment of traumatic brain injury.Application of FTIR spectroscopy for traumatic axonal injury: a possible tool for estimating injury intervalNeuroprotective Effects of CGP3466B on Apoptosis Are Modulated by Protein-L-isoaspartate (D-aspartate) O-methyltransferase/Mst1 Pathways after Traumatic Brain Injury in Rats.Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.Time courses of post-injury mitochondrial oxidative damage and respiratory dysfunction and neuronal cytoskeletal degradation in a rat model of focal traumatic brain injury.CONTINUOUS INFUSION OF PHENELZINE, CYCLOSPORINE A OR THE COMBINATION: EVALUATION OF MITOCHONDRIAL BIOENERGETICS, OXIDATIVE DAMAGE AND CYTOSKELETAL DEGRADATION FOLLOWING SEVERE CONTROLLED CORTICAL IMPACT TRAUMATIC BRAIN INJURY IN RATS.Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1.Development of a systems-based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury.Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.
P2860
Q28066813-9A20B8D7-F18E-4A10-9D58-9FC45F543F6EQ30959630-00CC2BEF-7834-43BD-9A58-3342A7B0E7BDQ34049949-F592A5A1-AA43-4CAF-A144-C2DCAB941022Q34250254-E63EF78E-ED7F-46FA-B56F-FA31415F26D4Q34314314-0D4DFA4B-5121-40BA-89B3-13B633CDDD9EQ35071145-0CCEA0A7-4CBD-447F-8414-67BC03FC6912Q35864073-4701DFA1-0E4D-40BC-9606-5702CBD3C460Q36745118-F9A796B3-2513-4B50-A096-B41D3F673398Q36768885-57BADDF4-BD8F-4FFA-85A8-601BA5CA3F75Q36804891-FE5E8608-81D6-4C5F-B07C-CC712262A483Q37045248-65ADFA70-C7EA-4ACD-9C64-C45DB17B8D68Q37982345-A3161F82-5C95-4211-A532-A78B6FAA1292Q38101157-1C167321-6A43-4635-A3A6-5DCA330708B7Q38181174-2FFE8C13-672F-4882-A1F6-6071FE5A3C26Q38188467-6B893C94-598B-43E7-B3B6-E27BB2EF0556Q38784156-E73AA46A-E861-40FF-AF10-F29372DDDEC2Q38824992-06BFE7EC-F346-4883-950A-9C6142C69AB1Q39012345-66215DD8-2D03-4F97-AFF6-5CB60BC85A78Q41490199-61D2F1A3-BA7A-4D05-9E8D-6EF99D6440D2Q41504076-F5A472A2-AC49-47BA-80AA-23B2D32F8A10Q45678701-DA8744F6-CBF1-46DE-9E93-48D1D3FCD7F3Q46396688-7427CB99-E645-4EBB-AC36-928B11B6D6A6Q47656401-35BD90D4-FD18-4E5F-9DC2-07F00D6331D1Q47887763-82DE7092-F59C-4E6B-86AA-A696167B8536Q48202029-DDBD0851-A6D5-4CDB-A1B4-D63B94C2C6BBQ48208413-3AD3FC26-0773-4414-95E4-D8305337024AQ48530059-BB0C18AE-7A9C-448F-8B21-BDCC79537BCC
P2860
Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacological inhibition of ...... after traumatic brain injury.
@ast
Pharmacological inhibition of ...... after traumatic brain injury.
@en
Pharmacological inhibition of ...... after traumatic brain injury.
@nl
type
label
Pharmacological inhibition of ...... after traumatic brain injury.
@ast
Pharmacological inhibition of ...... after traumatic brain injury.
@en
Pharmacological inhibition of ...... after traumatic brain injury.
@nl
prefLabel
Pharmacological inhibition of ...... after traumatic brain injury.
@ast
Pharmacological inhibition of ...... after traumatic brain injury.
@en
Pharmacological inhibition of ...... after traumatic brain injury.
@nl
P2093
P2860
P921
P1476
Pharmacological inhibition of ...... after traumatic brain injury.
@en
P2093
Ayman G Mustafa
Edward D Hall
Juan A Wang
Kimberly M Carrico
P2860
P304
P356
10.1111/J.1471-4159.2011.07228.X
P407
P577
2011-03-22T00:00:00Z